Pfizer Inc. (PFE) announced the sales of around 618 million ordinary shares in Haleon plc (HLN) at a price of 385 pence or about $5.01 per Ordinary Share for gross proceeds of approximately 2.4 billion pounds or approximately $3.1 billion. The transaction is expected to be finalized on March 21. After completing the Offering and Share Buyback, Pfizer will no longer own any shares or American depositary shares in Haleon. Haleon has agreed to buy about 44 million shares from Pfizer for around 170 million pounds or $220 million in a private transaction which is the share buyback. The price per share will be the same as in the Offering 385 pence or $5.01. The buyback will only proceed if the offering is completed.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.